PLoS One. 2014 Nov 25;9(11):e113188. doi: 10.1371/journal.pone.0113188. eCollection 2014 Palliative Care among Heart Failure Patients in Primary Care: A Comparison to Cancer Patients Using English Family Practice Data Gadoud A, Kane E, Macleod U, Ansell P, Oliver S, Johnson M Using the UK primary care database, Clinical Practice Research Datalink, this study explored if and when […]
Latest articles
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Safety alerts Patient Safety Alert for Potassium Permanganate NHS England has issued a patient safety alert (NHS/PSA/W/2014/18) warning of the risk of death or serious harm from accidental ingestion of potassium permanganate products. Potassium permanganate products are for […]
SHORTCUTS
Scand J Prim Health Care. 2014 Dec;32(4):187-92. doi: 10.3109/02813432.2014.972068. Epub 2014 Nov 3 Drug treatment at the end of life: An epidemiologic study in nursing homes Jansen K, Schaufel MA, Ruths S In a cohort study of 524 patients in three Norwegian nursing homes, diagnoses, drug prescriptions and demographic data were collected from electronic records. On […]
SHORTCUTS
Cancer. 2014 Nov 4. doi: 10.1002/cncr.29097. [Epub ahead of print] The symptom burden of treatment-naive patients with head and neck cancer Hanna EY, Mendoza TR, Rosenthal DI, Gunn GB, Sehra P, Yucel E, Cleeland CS In this retrospective study of 748 patients with head and neck cancer who have not received treatment, symptoms, quality of […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Safety Alerts Gabapentin and Pregabalin Potential for Misuse Public Health England and NHS England have published advice for prescribers on the risk of misuse of gabapentin and pregabalin. For more information, click here. Hot Topics Drugs […]
Metamorphosis of an upload
Do social media uploads, comments, blogs and videos provide rich opportunities for research or should we stand back on moral grounds? Answer: we need a framework By Dr Dafydd Brooks , Dr Mark Taubert, clinicians at Velindre Cancer Centre and Dr Annmarie Nelson and Dr Noreen Hopewell-Kelly, researchers at the Marie Curie Palliative Care Research Centre, […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Safety alerts Naloxone – Patient Safety Alert NHS England has produced a Patient Safety Alert warning of the risk of distress and death from inappropriate doses of naloxone in patients on long-term opioid treatment (NHS/PSA/W/2014/016R). The alert […]
SHORTCUTS
Eur J Pain. 2014 Aug 4. doi: 10.1002/ejp.567. [Epub ahead of print] A systematic review of therapeutic interventions to reduce acute and chronic post-surgical pain after amputation, thoracotomy or mastectomy Humble SR, Dalton AJ, Li L In this systematic review of perioperative interventions reducing acute and chronic pain associated with amputation, mastectomy or thoracotomy, 32 […]
Letter to the Editor – The use of the Deprivation of Liberty Safeguards in Palliative Care and the Cheshire West judgment: A Missed Opportunity?
To the Editor, The Deprivation of Liberty Safeguards (DoLS) were introduced on the 1st April 2009 to provide a framework for the lawful detention of individuals in hospitals (including hospices) or care homes who are unable to consent to their placement.1 The DoLS have come under increased scrutiny this year due to the Supreme Court […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Drug updates Nitrofurantoin contra-indications updated The guidance for using nitrofurantoin in renal impairment has changed. Nitrofurantoin is now contra-indicated in patients with an estimated glomerular filtration rate (eGFR) of <45mL/min/1.73m2. However, a short course (3–7 days) may be […]